Clinical trials are important for patients, they are beneficial to the NHS and they are good for the UK economy.
The UK has a world-leading research ecosystem for medicines discovery research, which is supported by a multitude of translational infrastructure and targeted funding streams for early-stage clinical research. However, in order to maintain and improve upon this excellence, we need to embrace new...
Following the publication of ‘Pharmaceutical companies’ policies on access to trial data, results, and methods: audit study’, the Association of the British Pharmaceutical Industry has issued the following statement.
“I won’t rest until we manage to deliver solutions that make blood cancer a manageable or even curable condition.” - Dr Catherine Taylor, Therapy Area Lead; Haemotology; Janssen Oncology; Europe, Middle East, Africa.
Have you ever wondered if the scientists you see in movies that are racing against the clock to prevent a deadly disease breakout actually exist?
Following the European Union's (EU) General Affairs Council decision to select Amsterdam, The Netherlands as the new location for the European Medicines Agency (EMA), the Association of the British Pharmaceutical Industry (ABPI) – the trade group for the pharmaceutical industry in the UK – have...
The Association of the British Pharmaceutical Industry (ABPI) have responded to a new study, published today in the British Medical Journal (BMJ), that suggests that clinical trials which are financially linked to the pharmaceutical industry have a ‘bias in the evidence base’.